Literature DB >> 2396155

Assessment of the 2.4 km run as a predictor of aerobic capacity.

S C Burger1, S R Bertram, R I Stewart.   

Abstract

Since the 2.4 km run time test is routinely used in military training programmes as an indicator of aerobic capacity and its possible improvement, an attempt was made to: (i) establish a regression equation of VO2max v. 2.4 km run time in a group of 20 young military volunteers; and (ii) determine whether this equation could be used to predict VO2max reliably from the 2.4 km time obtained from another group. Before and after training, VO2max was measured in all subjects using a treadmill test, and 2.4 km run time was determined in the field. Linear regression equations using the 2.4 km run time as the independent variable accounted for 76-92% of the variance in VO2max, while the standard error of the estimate varied from 2.24-2.91 ml/kg/min. In the second test group, the directly measured VO2max was 59.89 +/- 0.99 ml/kg/min, while the mean value estimated from the regression equation of the first group was 59.61 +/- 1.16 ml/kg/min (P less than 0.001). It was concluded that, in the population studied, the 2.4 km run time in the field reliably predicts VO2max measured during treadmill exercise in the laboratory.

Mesh:

Year:  1990        PMID: 2396155

Source DB:  PubMed          Journal:  S Afr Med J


  3 in total

1.  Relation of speed of a mile run, maximum energy cost of running, and maximum oxygen consumption: a field study.

Authors:  S K Das; A Dutta
Journal:  Br J Sports Med       Date:  1995-12       Impact factor: 13.800

2.  Effects of diet, physical activity and performance, and body weight on incident gout in ostensibly healthy, vigorously active men.

Authors:  Paul T Williams
Journal:  Am J Clin Nutr       Date:  2008-05       Impact factor: 7.045

Review 3.  Criterion-Related Validity of the Distance- and Time-Based Walk/Run Field Tests for Estimating Cardiorespiratory Fitness: A Systematic Review and Meta-Analysis.

Authors:  Daniel Mayorga-Vega; Raúl Bocanegra-Parrilla; Martha Ornelas; Jesús Viciana
Journal:  PLoS One       Date:  2016-03-17       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.